Work

Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.9088

Authors: Kathryn Cecilia Arbour, Biagio Ricciuti, Hira Rizvi, Matthew D. Hellmann, Helena Alexandra Yu, Marc Ladanyi, Mark G. Kris, Maria E. Arcila, Charles M. Rudin, Piro Lito, Mark M. Awad, Gregory J. Riely

Institutions: Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Massachusetts General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3170228209

Cites:

Cited by: 13

Related to: 10